Neurology

The prevalence of some neurodevelopmental disorders has increased in recent years. Although those disorders can have a genetic component, several external factors also play a role in the development of the disease. Therefore, Eurofins Clinical Diagnostics laboratories offer genetic testing to look for mutations, methylations and other alterations in the child’s genome. When the symptomatology is not clear, Whole Exome Sequencing (WES) is recommended.

Chronic headache and fibromyalgia can occur at the same time in many cases. Diagnosis of these diseases is not easy, and some patients suffer from not having a timely diagnosis. Clinical genetics offered at Eurofins laboratories can facilitate an easier and faster diagnosis. Patients that required to be medicated to treat depression, can suffer side-effects that make treatment adherence a challenge. Dosage personalization based on the genetic profile of each patient minimizes side effects and improves treatment outcome.

The difficulty in diagnosing Alzheimer's disease makes early treatment not always possible. For those predisposed to suffer the disease, genetic testing can allow them to start treatment early and slow down progression. Parkinson’s disease is usually diagnosed when motor symptoms appear. At that stage the disease is already quite advanced. Clinical genetic testing can help with early management of the disease, even before motor symptoms appear. Diagnosis via identification of particular mutations responsible for Amyotrophic Lateral Sclerosis (ALS) and Huntington’s disease are also available at Eurofins.